Competitive Intelligence
TAM and SAM Assessment
March 6, 20262.4K views
1
Objective
- Assessment of Total Addressable Market (TAM) and Total Serviceable Addressable Market (SAM) for strategic development of small molecule injectables within the key non-US markets
2
Approach
- Conducted indepth market assessment for key non-US markets like Australia, New Zealand, Japan, China, Western EU, Canada
- Identified and monitored key metrics like sales and volume to arrive at TAM and SAM
- Shortlisted unique molecules available in key therapy areas such as solid tumors, hematology and immunology, in each market
3
Outcome
- Identified the correct opportunity for the product using appropriate market filters
- Estimated the addressable market size for the client product
- Identified untapped opportunities for client product in new markets and therapy areas
- Mapped mandatory requirements and approval processes in each market set by the various regulatory bodies
- Finalized list of products for further clinical development and commercial launch
4
Client Benefits
- Helped gain comprehensive market understanding for the launch of products across all key regions
- Helped identify and measure KPIs that reflect the true performance of the product across markets and therapy areas
- Narrowed down to a list of products best suited for business expansion as per client’s strategic requirements
- Also got inputs for optimal utilization of existing work force and developmental capabilities